Clinical Trial Update: A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus [Phase 1]

View source ↗

Summary

This Phase 1 study completed evaluating escalating doses of a drug for the treatment of onychomycosis (nail fungus) sponsored by Stiefel, a GSK company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Onychomycosis | Phase 1 | Status: COMPLETED